NCT01279291: Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer |
|
|
| Terminated | 1 | 22 | US | KHK2866, Gemcitabine and Carboplatin, Gemzar, Paraplatin, paclitaxel, Taxol, pegylated liposomal doxorubicin, Doxil | Kyowa Kirin Co., Ltd., Kyowa Hakko Kirin Pharma, Inc. | Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Primary Peritoneal Neoplasm | 11/12 | 11/12 | | |
